-
Loading metrics
Open Access
Peer-reviewed
Research Article
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
-
Kylie M. Konrath ,
Contributed equally to this work with: Kylie M. Konrath, Kevin Liaw
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliations Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯ -
Kevin Liaw ,
Contributed equally to this work with: Kylie M. Konrath, Kevin Liaw
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Nicholas J. Tursi,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliations Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯ -
Madison E. McCanna,
Roles Conceptualization, Data curation, Investigation, Methodology, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Bryce M. Warner,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada, Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Canada
⨯ -
Ebony N. Gary,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Xizhou Zhu,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Cory Livingston,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Cara Monastra,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Drew Frase,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Neethu Chokkalingam,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Alana Huynh,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Nicholas Shupin,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Kelly Bayruns,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Sinja Kriete,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Amber Kim,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Joyce Park,
Roles Investigation, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Robert Vendramelli,
Roles Data curation, Investigation, Methodology, Supervision, Validation
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
⨯ -
Thang Truong,
Roles Investigation, Validation
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
⨯ -
Kevin Tierney,
Roles Investigation, Validation
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
⨯ -
Kimberly Azaransky,
Roles Investigation, Validation
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
⨯ -
Estella Moffat,
Roles Investigation, Validation
Affiliation National Center for Foreign Animal Disease (NCFAD), Canadian Food Inspection Agency, Winnipeg, Canada
⨯ -
Carissa Embury-Hyatt,
Roles Investigation, Validation
Affiliation National Center for Foreign Animal Disease (NCFAD), Canadian Food Inspection Agency, Winnipeg, Canada
⨯ -
Lynn A. Beer,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliation Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Oreoluwa Solanke,
Roles Formal analysis, Investigation, Validation
Affiliation Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Susanne N. Walker,
Roles Investigation, Resources, Validation
Affiliation Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Richa Kalia,
Roles Investigation, Validation
Affiliation Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, United States of America
⨯ -
Hsin-Yao Tang,
Roles Data curation, Investigation, Methodology, Validation
Affiliation Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
⨯ -
Laurent M.P.F. Humeau,
Roles Investigation, Supervision, Validation
Affiliation Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, United States of America
⨯ -
Trevor R.F. Smith,
Roles Investigation, Validation
Affiliation Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, United States of America
⨯ -
Darwyn Kobasa,
Roles Supervision
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
⨯ -
David B. Weiner ,
Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: dweiner@wistar.org (DBW); Daniel.Kulp@modernatx.com (DWK)
Affiliations Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯ - [ ... ],
-
Daniel W. Kulp
Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Software, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: dweiner@wistar.org (DBW); Daniel.Kulp@modernatx.com (DWK)
Current address: Moderna, Cambridge, Massachusetts, USA
Affiliations Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯ - [ view all ]
- [ view less ]
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
- Kylie M. Konrath,
- Kevin Liaw,
- Nicholas J. Tursi,
- Madison E. McCanna,
- Bryce M. Warner,
- Ebony N. Gary,
- Xizhou Zhu,
- Cory Livingston,
- Cara Monastra,
- Drew Frase
- Published: February 19, 2026
- https://doi.org/10.1371/journal.ppat.1013905